<?xml version='1.0' encoding='utf-8'?>
<document id="23161895"><sentence text="Adherence to drug-drug interaction alerts in high-risk patients: a trial of context-enhanced alerting." /><sentence text="Drug-drug interaction (DDI) alerting is an important form of clinical decision support, yet physicians often fail to attend to critical DDI warnings due to alert fatigue" /><sentence text=" We previously described a model for highlighting patients at high risk of a DDI by enhancing alerts with relevant laboratory data" /><sentence text=" We sought to evaluate the effect of this model on alert adherence in high-risk patients" /><sentence text="" /><sentence text="A 6-month randomized controlled trial involving 1029 outpatient physicians was performed" /><sentence text=" The target interactions were all DDIs known to cause hyperkalemia" /><sentence text=" Alerts in the intervention group were enhanced with the patient's most recent potassium and creatinine levels"><entity charOffset="79-88" id="DDI-PubMed.23161895.s8.e0" text="potassium" /><entity charOffset="93-103" id="DDI-PubMed.23161895.s8.e1" text="creatinine" /><pair ddi="false" e1="DDI-PubMed.23161895.s8.e0" e2="DDI-PubMed.23161895.s8.e0" /><pair ddi="false" e1="DDI-PubMed.23161895.s8.e0" e2="DDI-PubMed.23161895.s8.e1" /></sentence><sentence text=" The control group received unmodified alerts" /><sentence text=" High -risk patients were those with baseline potassium &gt;5"><entity charOffset="46-55" id="DDI-PubMed.23161895.s10.e0" text="potassium" /></sentence><sentence text="0 mEq/l and/or creatinine ≥1"><entity charOffset="15-25" id="DDI-PubMed.23161895.s11.e0" text="creatinine" /></sentence><sentence text="5 mg/dl (132 μmol/l)" /><sentence text="" /><sentence text="We found no significant difference in alert adherence in high-risk patients between the intervention group (15" /><sentence text="3%) and the control group (16" /><sentence text="8%) (p=0" /><sentence text="71)" /><sentence text=" Adherence in normal risk patients was significantly lower in the intervention group (14" /><sentence text="6%) than in the control group (18" /><sentence text="6%) (p&lt;0" /><sentence text="01)" /><sentence text=" In neither group did physicians increase adherence in patients at high risk" /><sentence text="" /><sentence text="Physicians adhere poorly to hyperkalemia-associated DDI alerts even in patients with risk factors for a clinically significant interaction, and the display of relevant laboratory data in these alerts did not improve adherence levels in the outpatient setting" /><sentence text=" Further research is necessary to determine optimal strategies for conveying patient-specific DDI risk" /><sentence text="" /></document>